Test Price
2,800 AED✅ Home Collection Available
MSTN Gene Muscle Hypertrophy Genetic Test in UAE – NGS Sequencing
Executive Summary & Core Metrics
- ✓ Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO‑accredited next‑generation sequencing (NGS) analysis of the MSTN gene.
- ✓ Premium Logistics: VIP mobile phlebotomy and temperature‑controlled cold‑chain home collection available daily from 8 AM to 11 PM.
- ✓ Clinical Guidance: Telephonic post‑test consultation included for result interpretation and genetic counselling referral.
- ✓ Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The MSTN (myostatin) gene test uses high‑throughput NGS to detect pathogenic variants associated with muscle hypertrophy, altered muscle mass regulation, and related neuromuscular phenotypes. Full gene coverage ensures identification of single‑nucleotide variants, small insertions/deletions, and splice‑site alterations with >99.9% analytical sensitivity. Results are interpreted according to ACMG/AMP guidelines and correlated with clinical presentation for definitive molecular diagnosis.
| Feature | Our Test (ISO 9001:2015) | Closest Alternative |
|---|---|---|
| Methodology | NGS – full gene coverage (coding + flanking intronic regions) | Sanger sequencing of selected exons only |
| Report Turnaround | 3–4 weeks | 6–8 weeks, often with longer analysis delays |
| Sample Types Accepted | Whole blood, extracted DNA, or one‑drop blood on FTA card | Blood only (requires higher volume) |
| Pre‑test Genetic Counselling | Included (pedigree charting and risk assessment) | Often requires separate referral |
| Cost | 2,800 AED | ~3,500 AED (limited coverage) |
Physician Insight & Safety Protocols
“The MSTN NGS panel provides molecular clarity for patients with unexplained muscle hypertrophy or suspected myostatin‑related disorders. Variant interpretation must always be integrated with the full clinical history, neurological examination, and family pedigree. I recommend that all findings be reviewed with a qualified medical geneticist before any lifestyle or therapeutic changes are made.” – Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not discontinue, adjust, or initiate any prescribed medication or supplement regimen based solely on genetic test results without direct consultation with your treating physician. This test is a diagnostic aid, not a substitute for comprehensive clinical evaluation.
Exclusion Criteria & Emergency Red Flags
- Active acute illness, recent blood transfusion within four weeks, or inability to provide informed consent in accordance with Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- Minors require legal guardian consent; unaccompanied minors are excluded from self‑referral.
- If the report identifies a pathogenic MSTN variant associated with sudden muscle weakness, respiratory difficulty, or cardiac symptoms, seek immediate emergency medical attention.
- Severe anxiety or psychological distress related to genetic testing – our team will facilitate referral to a licensed genetic counsellor.
Patient FAQ & Clinical Guidance
1. What is the MSTN gene muscle hypertrophy test?
This NGS test detects pathogenic and likely pathogenic variants in the myostatin (MSTN) gene that are associated with altered muscle mass regulation, hereditary muscle hypertrophy, and certain neuromuscular conditions. The analysis covers the entire coding region and conserved splice sites, providing a definitive molecular result that guides clinical management, athletic counselling, and family‑based risk assessment.
2. How is the sample collected and processed?
A certified phlebotomist visits your preferred location between 8 AM and 11 PM to collect a small volume of whole blood, or you may provide an extracted DNA sample or one‑drop blood on an FTA card. The specimen is transported under ISO‑certified temperature‑controlled cold chain to our Dubai Healthcare City laboratory. Nucleic acid is extracted, quality‑checked, and sequenced on a high‑throughput NGS platform. Raw data are processed through an accredited bioinformatics pipeline aligned with ACMG/AMP classification standards.
3. What will my results tell me and what are the next steps?
The report classifies each identified variant as benign, likely benign, variant of uncertain significance, likely pathogenic, or pathogenic. A post‑test teleconsultation with our clinical genetics team is included to explain the implications, discuss cascade testing for at‑risk relatives, and coordinate referral to a neurologist or sports medicine specialist if clinically warranted. Results should always be interpreted within the context of your personal and family medical history.
4. Who should consider this test and are there any limitations?
Individuals with unexplained muscle hypertrophy, a family history of myostatin‑related disorders, or athletes seeking molecular insights into muscle growth potential may consider this test. Limitations include the inability to detect large structural rearrangements, deep intronic variants, or epigenetic modifications. A negative result does not rule out all genetic causes of muscle hypertrophy. Pre‑test genetic counselling is recommended to ensure informed decision‑making.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Health Information Governance: All genetic data are processed and stored in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent procedures adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability. The laboratory operates under DHA Facility License No. 1143 and is ISO 9001:2015 certified.
For billing enquiries, appointment scheduling, or insurance pre‑approval, contact our patient services team via WhatsApp: +971 54 548 8731 | Landline: +971 4 548 8731 | Home collection hours: 8 AM – 11 PM daily.
Clinical & Logistical Metadata
| Test Name | MSTN Gene Muscle Hypertrophy Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole blood, extracted DNA, or one‑drop blood on FTA card |
| Methodology Used | Next‑Generation Sequencing (NGS) – full gene coverage |
| ICD-10-CM Code | M62.89 |
| LOINC Code | 101103-7 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | DNA Labs UAE | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians